nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—KCNH2—purkinje fiber—dilated cardiomyopathy	0.068	0.273	CbGeAlD
Doxepin—HTR2B—cardial valve—dilated cardiomyopathy	0.0439	0.176	CbGeAlD
Doxepin—KCNH2—endocardium—dilated cardiomyopathy	0.035	0.141	CbGeAlD
Doxepin—CYP2C9—cardial valve—dilated cardiomyopathy	0.0285	0.114	CbGeAlD
Doxepin—Drug fever—Spironolactone—dilated cardiomyopathy	0.0184	0.0486	CcSEcCtD
Doxepin—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.0154	0.0616	CbGeAlD
Doxepin—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0111	0.0293	CcSEcCtD
Doxepin—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00949	0.0381	CbGeAlD
Doxepin—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00949	0.025	CcSEcCtD
Doxepin—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00923	0.037	CbGeAlD
Doxepin—Indecainide—SCN5A—dilated cardiomyopathy	0.00923	0.508	CrCbGaD
Doxepin—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00605	0.0159	CcSEcCtD
Doxepin—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00569	0.015	CcSEcCtD
Doxepin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00551	0.0145	CcSEcCtD
Doxepin—Lethargy—Spironolactone—dilated cardiomyopathy	0.00456	0.012	CcSEcCtD
Doxepin—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00432	0.0114	CcSEcCtD
Doxepin—Ataxia—Spironolactone—dilated cardiomyopathy	0.0042	0.0111	CcSEcCtD
Doxepin—HRH2—heart—dilated cardiomyopathy	0.00409	0.0164	CbGeAlD
Doxepin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00402	0.0106	CcSEcCtD
Doxepin—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00386	0.0102	CcSEcCtD
Doxepin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00382	0.0101	CcSEcCtD
Doxepin—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00381	0.01	CcSEcCtD
Doxepin—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00373	0.205	CrCbGaD
Doxepin—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00372	0.00981	CcSEcCtD
Doxepin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00356	0.00937	CcSEcCtD
Doxepin—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00352	0.00927	CcSEcCtD
Doxepin—HRH2—cardiac atrium—dilated cardiomyopathy	0.0035	0.014	CbGeAlD
Doxepin—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00348	0.00919	CcSEcCtD
Doxepin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00344	0.00907	CcSEcCtD
Doxepin—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00334	0.00879	CcSEcCtD
Doxepin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00321	0.00847	CcSEcCtD
Doxepin—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.0031	0.00817	CcSEcCtD
Doxepin—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00295	0.0118	CbGeAlD
Doxepin—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00291	0.0117	CbGeAlD
Doxepin—Mental disability—Furosemide—dilated cardiomyopathy	0.00291	0.00766	CcSEcCtD
Doxepin—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00286	0.00754	CcSEcCtD
Doxepin—Viral infection—Lisinopril—dilated cardiomyopathy	0.00278	0.00733	CcSEcCtD
Doxepin—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00278	0.00733	CcSEcCtD
Doxepin—KCNH2—myocardium—dilated cardiomyopathy	0.00277	0.0111	CbGeAlD
Doxepin—ADRA2C—myocardium—dilated cardiomyopathy	0.00274	0.011	CbGeAlD
Doxepin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00273	0.0072	CcSEcCtD
Doxepin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00272	0.00716	CcSEcCtD
Doxepin—Deafness—Furosemide—dilated cardiomyopathy	0.00272	0.00716	CcSEcCtD
Doxepin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00269	0.0071	CcSEcCtD
Doxepin—CHRM2—heart—dilated cardiomyopathy	0.00268	0.0108	CbGeAlD
Doxepin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00259	0.00682	CcSEcCtD
Doxepin—Neck pain—Lisinopril—dilated cardiomyopathy	0.00254	0.0067	CcSEcCtD
Doxepin—Purpura—Furosemide—dilated cardiomyopathy	0.00252	0.00665	CcSEcCtD
Doxepin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0025	0.00658	CcSEcCtD
Doxepin—Lethargy—Furosemide—dilated cardiomyopathy	0.00248	0.00654	CcSEcCtD
Doxepin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00247	0.00651	CcSEcCtD
Doxepin—Wheezing—Lisinopril—dilated cardiomyopathy	0.00244	0.00643	CcSEcCtD
Doxepin—HTR2B—heart—dilated cardiomyopathy	0.00243	0.00974	CbGeAlD
Doxepin—Malaise—Spironolactone—dilated cardiomyopathy	0.00243	0.0064	CcSEcCtD
Doxepin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00241	0.00635	CcSEcCtD
Doxepin—Urinary retention—Furosemide—dilated cardiomyopathy	0.00231	0.00609	CcSEcCtD
Doxepin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00226	0.00597	CcSEcCtD
Doxepin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00221	0.00584	CcSEcCtD
Doxepin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00221	0.00583	CcSEcCtD
Doxepin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00219	0.00577	CcSEcCtD
Doxepin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00215	0.00567	CcSEcCtD
Doxepin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00208	0.00548	CcSEcCtD
Doxepin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00206	0.00542	CcSEcCtD
Doxepin—Eczema—Lisinopril—dilated cardiomyopathy	0.00203	0.00535	CcSEcCtD
Doxepin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00202	0.00532	CcSEcCtD
Doxepin—ADRA1A—heart—dilated cardiomyopathy	0.002	0.00804	CbGeAlD
Doxepin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.002	0.00528	CcSEcCtD
Doxepin—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00197	0.00518	CcSEcCtD
Doxepin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00195	0.00515	CcSEcCtD
Doxepin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00194	0.00512	CcSEcCtD
Doxepin—KCNH2—heart—dilated cardiomyopathy	0.00194	0.00777	CbGeAlD
Doxepin—ADRA2C—heart—dilated cardiomyopathy	0.00191	0.00766	CbGeAlD
Doxepin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0019	0.005	CcSEcCtD
Doxepin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00187	0.00494	CcSEcCtD
Doxepin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00186	0.00491	CcSEcCtD
Doxepin—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00183	0.101	CrCbGaD
Doxepin—Diplopia—Lisinopril—dilated cardiomyopathy	0.00182	0.00481	CcSEcCtD
Doxepin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00182	0.00481	CcSEcCtD
Doxepin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00181	0.00477	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00181	0.00477	CcSEcCtD
Doxepin—Sweating—Furosemide—dilated cardiomyopathy	0.0018	0.00473	CcSEcCtD
Doxepin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00177	0.00467	CcSEcCtD
Doxepin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00175	0.00461	CcSEcCtD
Doxepin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00174	0.0046	CcSEcCtD
Doxepin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00174	0.00458	CcSEcCtD
Doxepin—ABCB1—Lisinopril—dilated cardiomyopathy	0.00173	0.532	CbGbCtD
Doxepin—Ataxia—Lisinopril—dilated cardiomyopathy	0.00171	0.00452	CcSEcCtD
Doxepin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00166	0.00438	CcSEcCtD
Doxepin—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00166	0.00664	CbGeAlD
Doxepin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00165	0.00434	CcSEcCtD
Doxepin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00165	0.00434	CcSEcCtD
Doxepin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00164	0.00433	CcSEcCtD
Doxepin—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00163	0.00655	CbGeAlD
Doxepin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00163	0.0043	CcSEcCtD
Doxepin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00162	0.00426	CcSEcCtD
Doxepin—Asthma—Lisinopril—dilated cardiomyopathy	0.00158	0.00415	CcSEcCtD
Doxepin—Influenza—Lisinopril—dilated cardiomyopathy	0.00158	0.00415	CcSEcCtD
Doxepin—CYP2C9—heart—dilated cardiomyopathy	0.00157	0.00631	CbGeAlD
Doxepin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00157	0.00414	CcSEcCtD
Doxepin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00157	0.00413	CcSEcCtD
Doxepin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00156	0.00411	CcSEcCtD
Doxepin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00155	0.00409	CcSEcCtD
Doxepin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00153	0.00402	CcSEcCtD
Doxepin—ADRA2A—heart—dilated cardiomyopathy	0.00152	0.00611	CbGeAlD
Doxepin—ABCB1—Spironolactone—dilated cardiomyopathy	0.00152	0.468	CbGbCtD
Doxepin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00152	0.004	CcSEcCtD
Doxepin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00152	0.004	CcSEcCtD
Doxepin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0015	0.00396	CcSEcCtD
Doxepin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0015	0.00396	CcSEcCtD
Doxepin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0015	0.00395	CcSEcCtD
Doxepin—Dysuria—Lisinopril—dilated cardiomyopathy	0.00147	0.00388	CcSEcCtD
Doxepin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00146	0.00386	CcSEcCtD
Doxepin—Erythema—Furosemide—dilated cardiomyopathy	0.00146	0.00386	CcSEcCtD
Doxepin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00146	0.00386	CcSEcCtD
Doxepin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00145	0.00383	CcSEcCtD
Doxepin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00145	0.00383	CcSEcCtD
Doxepin—Flatulence—Furosemide—dilated cardiomyopathy	0.00144	0.0038	CcSEcCtD
Doxepin—Weight increased—Lisinopril—dilated cardiomyopathy	0.00143	0.00378	CcSEcCtD
Doxepin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00143	0.00378	CcSEcCtD
Doxepin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00141	0.00373	CcSEcCtD
Doxepin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00141	0.00371	CcSEcCtD
Doxepin—Vomiting—Spironolactone—dilated cardiomyopathy	0.0014	0.00368	CcSEcCtD
Doxepin—Rash—Spironolactone—dilated cardiomyopathy	0.00138	0.00365	CcSEcCtD
Doxepin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00138	0.00365	CcSEcCtD
Doxepin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00138	0.00364	CcSEcCtD
Doxepin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00138	0.00363	CcSEcCtD
Doxepin—Headache—Spironolactone—dilated cardiomyopathy	0.00138	0.00363	CcSEcCtD
Doxepin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00137	0.00361	CcSEcCtD
Doxepin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00137	0.0036	CcSEcCtD
Doxepin—Anaemia—Furosemide—dilated cardiomyopathy	0.00135	0.00357	CcSEcCtD
Doxepin—Sweating—Lisinopril—dilated cardiomyopathy	0.00135	0.00355	CcSEcCtD
Doxepin—Agitation—Furosemide—dilated cardiomyopathy	0.00134	0.00355	CcSEcCtD
Doxepin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00133	0.0035	CcSEcCtD
Doxepin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00132	0.00348	CcSEcCtD
Doxepin—Vertigo—Furosemide—dilated cardiomyopathy	0.00131	0.00347	CcSEcCtD
Doxepin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00131	0.00346	CcSEcCtD
Doxepin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00131	0.00345	CcSEcCtD
Doxepin—Nausea—Spironolactone—dilated cardiomyopathy	0.0013	0.00344	CcSEcCtD
Doxepin—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.0013	0.00523	CbGeAlD
Doxepin—HTR2A—heart—dilated cardiomyopathy	0.0013	0.0052	CbGeAlD
Doxepin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00128	0.00339	CcSEcCtD
Doxepin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00126	0.00333	CcSEcCtD
Doxepin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00126	0.00331	CcSEcCtD
Doxepin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00125	0.0033	CcSEcCtD
Doxepin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00125	0.00328	CcSEcCtD
Doxepin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00124	0.00328	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00124	0.00326	CcSEcCtD
Doxepin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00124	0.00326	CcSEcCtD
Doxepin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00122	0.00321	CcSEcCtD
Doxepin—Confusional state—Furosemide—dilated cardiomyopathy	0.0012	0.00318	CcSEcCtD
Doxepin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00118	0.0031	CcSEcCtD
Doxepin—Shock—Furosemide—dilated cardiomyopathy	0.00118	0.0031	CcSEcCtD
Doxepin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00117	0.00309	CcSEcCtD
Doxepin—Flushing—Lisinopril—dilated cardiomyopathy	0.00117	0.00309	CcSEcCtD
Doxepin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00117	0.00308	CcSEcCtD
Doxepin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00116	0.00306	CcSEcCtD
Doxepin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00115	0.00304	CcSEcCtD
Doxepin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00114	0.00302	CcSEcCtD
Doxepin—Anorexia—Furosemide—dilated cardiomyopathy	0.00114	0.003	CcSEcCtD
Doxepin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.003	CcSEcCtD
Doxepin—Chills—Lisinopril—dilated cardiomyopathy	0.00113	0.00298	CcSEcCtD
Doxepin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00113	0.00297	CcSEcCtD
Doxepin—Hypotension—Furosemide—dilated cardiomyopathy	0.00112	0.00294	CcSEcCtD
Doxepin—Alopecia—Lisinopril—dilated cardiomyopathy	0.00111	0.00294	CcSEcCtD
Doxepin—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00111	0.0614	CrCbGaD
Doxepin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00111	0.00291	CcSEcCtD
Doxepin—Erythema—Lisinopril—dilated cardiomyopathy	0.0011	0.00289	CcSEcCtD
Doxepin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.0011	0.00289	CcSEcCtD
Doxepin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00108	0.00285	CcSEcCtD
Doxepin—Tension—Lisinopril—dilated cardiomyopathy	0.00108	0.00284	CcSEcCtD
Doxepin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00108	0.00283	CcSEcCtD
Doxepin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00107	0.00283	CcSEcCtD
Doxepin—Nervousness—Lisinopril—dilated cardiomyopathy	0.00107	0.00281	CcSEcCtD
Doxepin—Back pain—Lisinopril—dilated cardiomyopathy	0.00106	0.0028	CcSEcCtD
Doxepin—Somnolence—Furosemide—dilated cardiomyopathy	0.00106	0.0028	CcSEcCtD
Doxepin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00106	0.00278	CcSEcCtD
Doxepin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00104	0.00274	CcSEcCtD
Doxepin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00103	0.00273	CcSEcCtD
Doxepin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00103	0.00272	CcSEcCtD
Doxepin—Fatigue—Furosemide—dilated cardiomyopathy	0.00103	0.00271	CcSEcCtD
Doxepin—Tremor—Lisinopril—dilated cardiomyopathy	0.00103	0.00271	CcSEcCtD
Doxepin—Pain—Furosemide—dilated cardiomyopathy	0.00102	0.00269	CcSEcCtD
Doxepin—Constipation—Furosemide—dilated cardiomyopathy	0.00102	0.00269	CcSEcCtD
Doxepin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.00269	CcSEcCtD
Doxepin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00101	0.00268	CcSEcCtD
Doxepin—Desipramine—SLC22A5—dilated cardiomyopathy	0.000992	0.0547	CrCbGaD
Doxepin—Malaise—Lisinopril—dilated cardiomyopathy	0.00099	0.00261	CcSEcCtD
Doxepin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000987	0.0026	CcSEcCtD
Doxepin—Syncope—Lisinopril—dilated cardiomyopathy	0.000985	0.0026	CcSEcCtD
Doxepin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000984	0.00259	CcSEcCtD
Doxepin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000983	0.00259	CcSEcCtD
Doxepin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000977	0.00257	CcSEcCtD
Doxepin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00097	0.00256	CcSEcCtD
Doxepin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000965	0.00254	CcSEcCtD
Doxepin—Cough—Lisinopril—dilated cardiomyopathy	0.000958	0.00253	CcSEcCtD
Doxepin—Urticaria—Furosemide—dilated cardiomyopathy	0.000949	0.0025	CcSEcCtD
Doxepin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000944	0.00249	CcSEcCtD
Doxepin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000944	0.00249	CcSEcCtD
Doxepin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000935	0.00246	CcSEcCtD
Doxepin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000935	0.00246	CcSEcCtD
Doxepin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000935	0.00246	CcSEcCtD
Doxepin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000932	0.00246	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000928	0.00245	CcSEcCtD
Doxepin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000924	0.00244	CcSEcCtD
Doxepin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000914	0.00241	CcSEcCtD
Doxepin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000904	0.00238	CcSEcCtD
Doxepin—Oedema—Lisinopril—dilated cardiomyopathy	0.000896	0.00236	CcSEcCtD
Doxepin—Infection—Lisinopril—dilated cardiomyopathy	0.00089	0.00235	CcSEcCtD
Doxepin—Shock—Lisinopril—dilated cardiomyopathy	0.000882	0.00232	CcSEcCtD
Doxepin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00088	0.00232	CcSEcCtD
Doxepin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000877	0.00231	CcSEcCtD
Doxepin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000875	0.00231	CcSEcCtD
Doxepin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00087	0.00229	CcSEcCtD
Doxepin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000866	0.00228	CcSEcCtD
Doxepin—Asthenia—Furosemide—dilated cardiomyopathy	0.000857	0.00226	CcSEcCtD
Doxepin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000854	0.00225	CcSEcCtD
Doxepin—ABCB1—heart—dilated cardiomyopathy	0.000849	0.00341	CbGeAlD
Doxepin—Pruritus—Furosemide—dilated cardiomyopathy	0.000845	0.00223	CcSEcCtD
Doxepin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000837	0.00221	CcSEcCtD
Doxepin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000817	0.00215	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000816	0.00215	CcSEcCtD
Doxepin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000811	0.00214	CcSEcCtD
Doxepin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000805	0.00212	CcSEcCtD
Doxepin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000799	0.00211	CcSEcCtD
Doxepin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000797	0.0021	CcSEcCtD
Doxepin—Dizziness—Furosemide—dilated cardiomyopathy	0.00079	0.00208	CcSEcCtD
Doxepin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000789	0.00208	CcSEcCtD
Doxepin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000779	0.00205	CcSEcCtD
Doxepin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000774	0.00204	CcSEcCtD
Doxepin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000773	0.00204	CcSEcCtD
Doxepin—Pain—Lisinopril—dilated cardiomyopathy	0.000766	0.00202	CcSEcCtD
Doxepin—Constipation—Lisinopril—dilated cardiomyopathy	0.000766	0.00202	CcSEcCtD
Doxepin—Vomiting—Furosemide—dilated cardiomyopathy	0.000759	0.002	CcSEcCtD
Doxepin—Rash—Furosemide—dilated cardiomyopathy	0.000753	0.00199	CcSEcCtD
Doxepin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000752	0.00198	CcSEcCtD
Doxepin—Headache—Furosemide—dilated cardiomyopathy	0.000748	0.00197	CcSEcCtD
Doxepin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000738	0.00195	CcSEcCtD
Doxepin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000733	0.00193	CcSEcCtD
Doxepin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000712	0.00188	CcSEcCtD
Doxepin—Nausea—Furosemide—dilated cardiomyopathy	0.000709	0.00187	CcSEcCtD
Doxepin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000708	0.00187	CcSEcCtD
Doxepin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000708	0.00187	CcSEcCtD
Doxepin—Desipramine—ADRB1—dilated cardiomyopathy	0.000685	0.0377	CrCbGaD
Doxepin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00066	0.00174	CcSEcCtD
Doxepin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000643	0.0017	CcSEcCtD
Doxepin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000634	0.00167	CcSEcCtD
Doxepin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000613	0.00162	CcSEcCtD
Doxepin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000593	0.00156	CcSEcCtD
Doxepin—Desipramine—ADRB2—dilated cardiomyopathy	0.000576	0.0317	CrCbGaD
Doxepin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00057	0.0015	CcSEcCtD
Doxepin—Rash—Lisinopril—dilated cardiomyopathy	0.000565	0.00149	CcSEcCtD
Doxepin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000565	0.00149	CcSEcCtD
Doxepin—Headache—Lisinopril—dilated cardiomyopathy	0.000561	0.00148	CcSEcCtD
Doxepin—Nausea—Lisinopril—dilated cardiomyopathy	0.000532	0.0014	CcSEcCtD
Doxepin—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.47e-05	0.000128	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	4.46e-05	0.000128	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.46e-05	0.000127	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.44e-05	0.000127	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.43e-05	0.000127	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.43e-05	0.000127	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.43e-05	0.000127	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.42e-05	0.000126	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.42e-05	0.000126	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.41e-05	0.000126	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.41e-05	0.000126	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.4e-05	0.000126	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.4e-05	0.000126	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.4e-05	0.000126	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.39e-05	0.000125	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.39e-05	0.000125	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.39e-05	0.000125	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.38e-05	0.000125	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—RAF1—dilated cardiomyopathy	4.37e-05	0.000125	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.35e-05	0.000124	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.35e-05	0.000124	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.34e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.34e-05	0.000124	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.34e-05	0.000124	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.32e-05	0.000123	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.31e-05	0.000123	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.29e-05	0.000123	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.25e-05	0.000122	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.25e-05	0.000121	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.24e-05	0.000121	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.22e-05	0.000121	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.21e-05	0.00012	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.2e-05	0.00012	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.19e-05	0.00012	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.17e-05	0.000119	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.16e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.15e-05	0.000119	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.15e-05	0.000119	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	4.12e-05	0.000118	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.12e-05	0.000118	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.11e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.1e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.1e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.08e-05	0.000117	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.08e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.07e-05	0.000116	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.06e-05	0.000116	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.05e-05	0.000116	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.05e-05	0.000116	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.04e-05	0.000116	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.04e-05	0.000115	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.03e-05	0.000115	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.03e-05	0.000115	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.03e-05	0.000115	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	4.02e-05	0.000115	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.02e-05	0.000115	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.99e-05	0.000114	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.98e-05	0.000114	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.98e-05	0.000114	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.98e-05	0.000114	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.97e-05	0.000113	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.97e-05	0.000113	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.96e-05	0.000113	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.95e-05	0.000113	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.94e-05	0.000113	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.94e-05	0.000112	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.92e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.91e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.87e-05	0.000111	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.86e-05	0.00011	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.82e-05	0.000109	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.78e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.75e-05	0.000107	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	3.75e-05	0.000107	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.75e-05	0.000107	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.74e-05	0.000107	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.74e-05	0.000107	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.72e-05	0.000106	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	3.7e-05	0.000106	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.69e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.69e-05	0.000105	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.69e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	3.66e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.63e-05	0.000104	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.62e-05	0.000103	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.59e-05	0.000103	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.58e-05	0.000102	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	3.57e-05	0.000102	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.56e-05	0.000102	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	3.54e-05	0.000101	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	3.54e-05	0.000101	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.46e-05	9.89e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	3.42e-05	9.77e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.41e-05	9.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.4e-05	9.71e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.39e-05	9.69e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.39e-05	9.68e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	3.39e-05	9.67e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.38e-05	9.65e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.38e-05	9.65e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.34e-05	9.55e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.34e-05	9.53e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.33e-05	9.52e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.33e-05	9.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.28e-05	9.38e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.26e-05	9.31e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.24e-05	9.26e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	3.24e-05	9.26e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.23e-05	9.23e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.23e-05	9.23e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.22e-05	9.21e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.21e-05	9.18e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.21e-05	9.18e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	3.21e-05	9.17e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.2e-05	9.15e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.2e-05	9.13e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.18e-05	9.09e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.17e-05	9.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.16e-05	9.04e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CD36—dilated cardiomyopathy	3.16e-05	9.02e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.15e-05	9.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.11e-05	8.88e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.1e-05	8.87e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.1e-05	8.85e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.06e-05	8.74e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.02e-05	8.63e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.01e-05	8.59e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—EGFR—dilated cardiomyopathy	3e-05	8.57e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	2.97e-05	8.5e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.94e-05	8.4e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.9e-05	8.3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	2.9e-05	8.27e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.89e-05	8.25e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	2.87e-05	8.21e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.86e-05	8.18e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.85e-05	8.14e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AGT—dilated cardiomyopathy	2.84e-05	8.12e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.82e-05	8.06e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.82e-05	8.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.81e-05	8.03e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.81e-05	8.03e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.8e-05	8e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.79e-05	7.98e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.78e-05	7.93e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.77e-05	7.93e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.77e-05	7.91e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.77e-05	7.9e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.76e-05	7.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.76e-05	7.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.76e-05	7.88e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.76e-05	7.88e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.76e-05	7.87e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.75e-05	7.86e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.73e-05	7.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.73e-05	7.79e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.72e-05	7.77e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.68e-05	7.67e-05	CbGpPWpGaD
Doxepin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.67e-05	7.63e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.64e-05	7.55e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.61e-05	7.45e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	2.6e-05	7.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.56e-05	7.33e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.56e-05	7.32e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.55e-05	7.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.53e-05	7.22e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.51e-05	7.17e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.5e-05	7.15e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.5e-05	7.13e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.49e-05	7.11e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.46e-05	7.04e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.46e-05	7.02e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.45e-05	7.01e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	2.44e-05	6.96e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.4e-05	6.85e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	2.39e-05	6.83e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-05	6.81e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	2.38e-05	6.79e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.37e-05	6.78e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	2.35e-05	6.72e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	2.35e-05	6.71e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.35e-05	6.7e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.33e-05	6.64e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.32e-05	6.61e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.28e-05	6.52e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.24e-05	6.39e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.22e-05	6.35e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.21e-05	6.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.18e-05	6.23e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.16e-05	6.18e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.13e-05	6.08e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.11e-05	6.02e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.06e-05	5.87e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.05e-05	5.86e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2e-05	5.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.99e-05	5.7e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.96e-05	5.61e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.94e-05	5.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.93e-05	5.52e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.93e-05	5.5e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.93e-05	5.5e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.92e-05	5.49e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.92e-05	5.49e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.92e-05	5.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.91e-05	5.47e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.9e-05	5.42e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.89e-05	5.4e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.89e-05	5.39e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.87e-05	5.34e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.86e-05	5.32e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.85e-05	5.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.83e-05	5.24e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.8e-05	5.15e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	1.78e-05	5.1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.76e-05	5.02e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.7e-05	4.85e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.69e-05	4.83e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.68e-05	4.81e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.68e-05	4.81e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.66e-05	4.75e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.66e-05	4.74e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-05	4.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.65e-05	4.71e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.64e-05	4.69e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	4.67e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	4.65e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.63e-05	4.65e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.61e-05	4.6e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.6e-05	4.57e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.52e-05	4.33e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.51e-05	4.32e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	1.44e-05	4.11e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.37e-05	3.91e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.32e-05	3.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.31e-05	3.75e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.28e-05	3.65e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.27e-05	3.62e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.26e-05	3.59e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.23e-05	3.53e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.16e-05	3.31e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.14e-05	3.26e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.14e-05	3.25e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-05	3.24e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.13e-05	3.23e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	3.2e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	3.19e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.11e-05	3.17e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.04e-05	2.96e-05	CbGpPWpGaD
